Cary Street Partners’s Zomedica Corp. ZOM Stock Holding History

Cary Street Partners’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-11,300	Closed	-$892	–	1021
2025 Q3	$892	Hold	11,300	–	–	﹤0.01%	924
2025 Q2	$457	Hold	11,300	–	–	﹤0.01%	899
2025 Q1	$655	Hold	11,300	–	–	﹤0.01%	857
2024 Q4	$1.36K	Buy	+11,300	New	+$1.42K	﹤0.01%	826

Other funds holding ZOM

JWM

Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

SIS

Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return

BWL

Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Cary Street Partners's ZOM Position: Q4 2025 in Review

Cary Street Partners sold out of Zomedica Corp. (ZOM) in Q4 2025, closing a stake of 11,300 shares — an estimated $892 sold.

Cary Street Partners first reported a position in ZOM in Q4 2024 and held it in 4 quarters. The position peaked at $1.36K in Q4 2024. 7 funds tracked by Wall St. Rank hold ZOM as of Q4 2025.

Cary Street Partners reported no remaining Zomedica Corp. position as of Q4 2025 after selling out during the quarter.
Cary Street Partners sold 11,300 Zomedica Corp. shares in Q4 2025, an estimated $892.
Cary Street Partners first reported a position in Zomedica Corp. in Q4 2024 and held it in 4 quarters.
Cary Street Partners's Zomedica Corp. position peaked at $1.36K in Q4 2024.
7 funds tracked by Wall St. Rank held Zomedica Corp. as of Q4 2025.

Based on Cary Street Partners's 13F filing for Q4 2025, filed 9 Feb 2026.